Clinical Trials Logo

Filter by:
NCT ID: NCT04625062 Completed - Clinical trials for Speech Sound Disorder

Comparing Traditional and Biofeedback Telepractice Treatment for Residual Speech Errors

C-RESULTS TPT
Start date: September 1, 2020
Phase: Phase 1
Study type: Interventional

This study aims to evaluate the relative efficacy of biofeedback and traditional treatment for residual speech errors when both are delivered via telepractice. In a single-case randomization design, up to eight children with RSE will receive both visual-acoustic biofeedback and traditional treatment via telepractice. Acoustic measures of within-session change will be compared across sessions randomly assigned to each condition. It is hypothesized that participants will exhibit a clinically significant overall treatment response and that short-term measures of change will indicate that biofeedback is associated with larger increments of progress than traditional treatment.

NCT ID: NCT04624919 Completed - Hyperthermia Clinical Trials

Comparison of Fatigue in Varying Hot Environments

Start date: December 10, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the impact of varying hot environments on physiological and perceptual fatigue during work.

NCT ID: NCT04624620 Completed - Obesity Clinical Trials

A Culinary-Based Intensive Lifestyle Program for Patients With Obesity

TKCC
Start date: January 11, 2022
Phase: N/A
Study type: Interventional

The study team proposes in this pilot to test, in a single-arm mixed-methods study, the feasibility, acceptability, and preliminary effectiveness of the 16 modular classes taught by a chef, dietitian, and health coach. While the pilot may not have the power to detect significant change, it will provide preliminary data for a NIH application to further test this curriculum in a pragmatic, community-based, randomized multi-site Teaching Kitchen Collaborative Curriculum (TKCC) study planned for Jan 2022 or thereafter. If effective, the TKCC has potential to impact population health through translation into teaching kitchens nationally and adaptation to clinic /community settings.

NCT ID: NCT04624607 Completed - Clinical trials for Spinal Cord Injuries

Transspinal-Transcortical Paired Stimulation for Neuroplasticity and Recovery After SCI

Start date: January 5, 2018
Phase: N/A
Study type: Interventional

People with spinal cord injury (SCI) have motor dysfunction that results in substantial social, personal, and economic costs. Uncontrolled muscle spasticity and motor dysfunction result in disabilities that significantly reduce quality of life. Several rehabilitation interventions are utilized to treat muscle spasticity and motor dysfunction after SCI in humans. However, because most interventions rely on sensory afferent feedback that is interpreted by malfunctioned neuronal networks, rehabilitation efforts are greatly compromised. On the other hand, changes in the function of nerve cells connecting the brain and spinal cord have been reported following repetitive electromagnetic stimulation delivered over the head and legs or arms at specific time intervals. In addition, evidence suggests that electrical signals delivered to the spinal cord can regenerate spinal motor neurons in injured animals. A fundamental knowledge gap still exists on neuroplasticity and recovery of leg motor function in people with SCI after repetitive transspinal cord and transcortical stimulation. In this project, it is proposed that repetitive pairing of transspinal cord stimulation with transcortical stimulation strengthens the connections between the brain and spinal cord, decreases ankle spasticity, and improves leg movement. People with motor incomplete SCI will receive transspinal - transcortical paired associative stimulation at rest and during assisted stepping. The effects of this novel neuromodulation paradigm will be established via clinical tests and noninvasive neurophysiological methods that assess the pathways connecting the brain with the spinal cord.

NCT ID: NCT04624594 Completed - Squat Form Clinical Trials

AI Mobile Application Versus HCP for Bodyweight Squats

Start date: October 15, 2019
Phase: N/A
Study type: Interventional

To assess if an artificial intelligence (AI) mobile application can identify and improve bodyweight squat form in adult participants when compared to a Physical Therapist (PT).

NCT ID: NCT04624165 Completed - Oncology Clinical Trials

Patient Perspective of Telemedicine in Gynecology Oncology

Start date: January 21, 2021
Phase:
Study type: Observational

Research question: do patients in a gynecologic oncology practice value the use of telemedicine as an adjunct to in-person visits and in what circumstances might patients not find these visits to be sufficient?

NCT ID: NCT04624152 Completed - Trauma, Brain Clinical Trials

The Role of Hypoxia on Subconcussive Head Impacts

Start date: October 22, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the combined effects of hypoxia and a short bout of subconcussive head impacts on neurocognitive and ocular-motor function and plasma expression of brain-derived blood biomarkers.

NCT ID: NCT04624087 Completed - Clinical trials for Overweight and Obesity

Go/No-Go Intervention for Weight Loss

Start date: October 19, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of a food-specific Go/No-Go (GNG) computerized training task on weight loss, food evaluation, and disinhibition in a population of overweight and obese individuals.

NCT ID: NCT04623736 Completed - Tobacco Use Clinical Trials

Smartphone Application Smoking Cessation Study

Start date: October 19, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if using the smartphone application quitSTART can help people quit smoking and to understand how use of specific smartphone application features when trying to quit smoking is associated with success.

NCT ID: NCT04623710 Completed - Healthy Clinical Trials

Study of ALXN2050 in Participants With Renal Impairment

Start date: July 8, 2021
Phase: Phase 1
Study type: Interventional

This study will investigate the impact of impaired renal function on the plasma pharmacokinetics of ALXN2050 in order to provide dosing recommendations for future indications in individuals with impaired renal function.